Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 1Motor Activity 1Lung Neoplasms 1Inflammation 1

Interventions

Tobacco Use Cessation Devices 11Varenicline 9Surveys and Questionnaires 9Standard of Care 6Nicotine Replacement Therapy 6Motivational Interviewing 4Ethanol 4Smoking Devices 3Preoperative Exercise 3Methods 3Videotape Recording 2Tomography, X-Ray Computed 2Tobacco Products 2Secondary Prevention 2Nicotine Chewing Gum 2Mindfulness 2Interviews as Topic 2Hematologic Tests 2Focus Groups 2Cognitive Behavioral Therapy 2Carbon Monoxide 2thiamine triphosphorate 1sulforaphane 1polyphenon E 1cytisine 1Yoga 1Urinalysis 1Transdermal Patch 1Transcranial Direct Current Stimulation 1Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Smoking Cessation × cytisine × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡